incretin raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-01-27 and is reviewed periodically as new material appears.
Retatrutide is an investigational peptide developed by a pharmaceutical company as a multi-receptor agonist for treating obesity and type 2 diabetes. The compound emerged from research into gut-hormone analogues that act on several receptors simultaneously rather than on a single target. Early preclinical work examined how combined activity at three distinct receptors might produce greater metabolic effects than single-receptor compounds. Published phase 2 results have described substantial reductions in body weight among participants, although the compound remains unapproved in most jurisdictions as of the mid-2020s.
Pharmacologically, retatrutide acts as a triple agonist at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor. Activation of the first two receptors is associated with improved insulin secretion and reduced appetite. The glucagon receptor component is thought to increase energy expenditure, a mechanism that distinguishes this molecule from dual-agonist compounds. Researchers continue to investigate how the three activities interact and whether the combined profile offers advantages that justify additional clinical testing.
Several questions about the compound remain unresolved. The durability of weight reduction after treatment stops, the frequency of gastrointestinal side effects, and the long-term cardiovascular profile are topics of ongoing study. Regulatory submissions and phase 3 trial outcomes have not been fully reported in the public literature. Because most available data come from controlled trials rather than general-population use, conclusions about effectiveness outside study settings are provisional. The distinction between established findings and open questions matters when interpreting early coverage of the drug.
冻干粉通常在低温环境下保存，复溶之后需要按指定条件在较短时间内使用。反复冻融和剧烈振荡可能促进聚集，低吸附容器则能减少多肽在管壁上的损失。批号、日期与处理条件的完整记录，是后续复核与问题追溯的基础。
供应环节涉及来源核实与文件审核两类工作。分析证书、批次记录以及第三方检测报告构成常见的可追溯材料。来源不清的样品很难确认身份与纯度，因此核实步骤在实际操作中具有明确意义。缺少方法细节的报告通常无法复核。
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Contains non-natural residues |
| Receptor targets | GLP-1, GIP, glucagon | Triple agonist profile |
| Route of administration | Subcutaneous injection | In clinical trial settings |
| Development status | Investigational | Not approved in major markets |
| Approximate molecular mass | About 4.7 kDa | Peptide-scale molecule |
Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.
Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.
Receptor activation produces downstream effects that differ by tissue. GLP-1 receptor signaling influences appetite regulation and insulin secretion in a glucose-dependent manner. GIP receptor activity contributes to metabolic handling of nutrients and may modulate adipose tissue. Glucagon receptor engagement raises energy expenditure and promotes hepatic lipid turnover, though the balance among these actions in humans is still being characterized. Preclinical models showed reductions in body weight and improved glycemic markers.
The three-receptor design places retatrutide in a distinct category relative to older incretin-based therapies. Single agonists target one receptor, and dual agonists target two. Adding a third target broadens the pharmacological footprint and introduces new trade-offs among efficacy, tolerability, and glucose control. How these trade-offs resolve in large trials is a central focus of current research.
Retatrutide is an investigational peptide studied for obesity and type 2 diabetes. It is a single synthetic molecule designed to activate three metabolic receptors simultaneously. The compound belongs to the incretin mimetic family, a group of peptides that imitate gut hormones involved in appetite and glucose control. Its research code is LY3437943, and it remains under clinical study rather than cleared for routine medical use.
与仅靶向单一受体的同类药物相比，瑞他鲁肽增加胰高血糖素受体成分，理论上可提高能量消耗并改变脂肪分布。临床中观察到的体重变化是否主要来自该额外机制，目前尚无定论。胃肠道反应是该类药物常见不良事件，试验中通过剂量递增和监测进行管理。停药后体重反弹、个体差异和长期耐受性仍需更多数据。
瑞他鲁肽是一种在研合成肽，同时作用于胰高血糖素样肽-1、葡萄糖依赖性促胰岛素多肽和胰高血糖素受体。该分子属于多受体激动剂类别，尚未获得任何监管机构的上市批准。当前临床开发主要针对肥胖和2型糖尿病，研究代号为LY3437943。已确立的信息包括受体靶点和部分中期试验结果；最终疗效、长期安全性和适用人群仍属开放问题。
开发进程从早期单次和多次给药研究推进至大规模后期试验。公开报告显示，参与者在体重和相关代谢指标上出现变化，但完整数据需经同行评审并接受独立复核。试验设计通常包括随机、双盲和对照设置，以区分药物效应与行为干预。监管提交和标签范围尚未确定；长期维持效果与心血管结局仍是开放问题。
=== Business === Morea has been involved in multiple entrepreneurial initiatives. In 2012, he co-founded the merchandising company Cool Maal with cricketer MS Dhoni and Yuvraj Singh. He later established Clockwise Films, a production company, in 2013. That same year, he co-founded a lifestyle and entertainment venture called Playground with Nandita Mahtani. He has partnership with a photo sharing app called Vebbler. He owns a restaurants named Crepe Station Café in Bandra. It is one of the fastest developing chains in India which offers pancakes, waffles and eggs benedict. In 2013, he initiated the installation of outdoor fitness stations in Wadala and Bandra, Mumbai. These facilities were inaugurated with the involvement of actor Hrithik Roshan and politician Aaditya Thackeray. In 2019, Morea and restaurateur Ketan Kadam received an award from People for the Ethical Treatment of Animals (PETA) for a project aimed at replacing horse-drawn carriages in Mumbai with battery-operated electric vehicles. He is also the co-founder of The Fresh Press, a cold-pressed juice brand, and serves as a board director at the Gruhas Collective Consumer Fund (GCCF), an investment platform focused on consumer brands.
=== Part Two === The Purchase Brothers had initially planned to release the second part of the film in early to mid-March 2009, but the large number of emails and phone calls the two received regarding the first part slowed development of the second. According to teaser clips at the end of the first part, the two Resistance soldiers will be joined by two additional characters, one of them a heroine, and will come into contact with headcrab zombies. The Purchase Brothers cited on their YouTube profile page that a new secret film project has heavily hampered their progress in completing Part Two, although it would be released in the near future. Another teaser clip was released on YouTube on October 13, 2009. Part Two was released on YouTube on August 19, 2011. The clip was quickly removed for unknown reasons by the end of the same day with no further comment on why it was removed. It was re-uploaded on August 24, 2011.
==== Synthesis of crown ethers ==== A series of polynomial heterocyclic compounds, known as crown ethers, can be synthesized with ethylene oxide. One method is the cationic cyclopolymerization of ethylene oxide, limiting the size of the formed cycle:
Norman Geras (25 August 1943 – 18 October 2013); political theorist of Rhodesian Jewish origin; Professor Emeritus of Politics at the University of Manchester; author of over ten scholarly and historical texts, mostly focused on radical politics; contributed to analysis of Karl Marx in Marx and Human Nature; in 2006, he was one of the principal authors of the Euston Manifesto. Martin Gilbert (25 October 1936 – 3 February 2015); historian and honorary Fellow of Merton College, Oxford; author of 88 books, including works on Winston Churchill, the 20th century, and Jewish history including the Holocaust; was a member of the Chilcot Inquiry into Britain's role in the Iraq War; noted for his endorsement of Bat Ye'or and Eurabia theory, providing comment for her book, stating that the theory "is 100 percent accurate". One of Gilbert's last books, In Ishmael's House: A History of the Jews in Muslim Lands cited Ye'or with approval several times. Morris Ginsberg FBA (14 May 1889 – 31 August 1970) British sociologist and prolific author who played a key role in the development of the discipline of sociology. He served as editor of The Sociological Review in the 1930s and later became the founding chairman of the British Sociological Association in 1951 and its first President (1955–1957). He was president of the Aristotelian Society from 1942 to 1943, and helped draft the UNESCO 1950 statement titled The Race Question.
Sources: en.wikipedia.org
=== In film === The sedative effects of Trimipramine in off-prescription, recreational use are described in the 1987 film Withnail and I where the eponymous character declares "This is the plan. We get in there and get wrecked, then we'll eat a pork pie, then we'll drop a couple of Surmontil-50's each. That means we'll miss out Monday but come up smiling Tuesday morning."
=== Polysaccharides === Certain compounds found in mushrooms, primarily polysaccharides, can up-regulate the immune system and may have anti-cancer properties. For example, beta-glucans such as lentinan have been shown in laboratory studies to stimulate macrophage, NK cells, T cells and immune system cytokines and have been investigated in clinical trials as immunologic adjuvants.
Through "neural lace", a form of brain–computer interface that is implanted into the brains of young people and grows with them, the Culture has the capability to read and store the full sentience of any being, biological or artificial, and thus reactivate a stored being after its death. The neural lace also allows wireless communication with the Minds and databases. This also necessitates the capability to read thoughts, but as described in Look to Windward, doing this without permission is considered taboo.
== Career == Huttenlocher joined the faculty at the University of Wisconsin–Madison (UW-M) in 1999 with a joint appointment in the Departments of Pediatrics and Pharmacology, and as an associate director of the Medical Scientist Training Program (MSTP). In this role, Huttenlocher's research has defined cellular and molecular mechanisms that regulate cell migration and identified basic adhesive mechanisms that regulate cell migration and leukocyte chemotaxis. By 2005, her research team had identified a novel pathway that turned out to be critical for cell migration and chemotaxis, involving intracellular proteolysis by the calcium-dependent protease calpain. Her laboratory was also the first to document reverse migration of neutrophils away from sites of injury or inflammation. In 2011 her group reported the first redox sensor that mediates leukocyte attraction to wounds. In 2005 she was elected a member of the American Society for Clinical Investigation. Huttenlocher was promoted to Professor with tenure in 2008 and was the recipient of the Graduate School’s H.I. Romnes Fellowship award. She also received the Burroughs-Wellcome Fund’s Clinical Scientist Award in Translational Research for her project "Diagnosis and Treatment of Autoinflammatory Disease." Huttenlocher was the recipient of a 2011 WARF Kellett Mid-Career Award. Until 2023 she conducted this work while maintaining an active clinical practice as a pediatric rheumatologist. In 2012, Huttenlocher was appointed as Director of the UW-Madison MD-PhD training program (MSTP), succeeding Deane Mosher.
== Formation == Thionyl fluoride reacting with fluorine gas can produce thionyl tetrafluoride. This was how the gas was first discovered by Moissan and Lebeau in 1902. They identified the formula by the pressure changes resulting from the reaction. Silver fluoride and platinum are capable of catalyzing the reaction. It can also be formed from the reaction of silver difluoride with thionyl fluoride at 392 °F (200 °C), or by electrolyzing hydrogen fluoride with a solution of sulfur dioxide, which also made oxygen difluoride and sulfuryl fluoride. Thionyl chloride or thionyl fluoride electrolyzed with hydrogen fluoride produced even more of the gas.
Sources: en.wikipedia.org
== Variations == Other boneless chuck cuts include the chuck eye (boneless cuts from the center of the roll, sold as Delmonico steak or chuck eye steak), chuck fillet (sold as chuck tender steak or mock tender steak), cross-rib roast (sold as cross-rib pot roast, English roast, or "the bread and butter cut"), top blade steak or chicken steak, under-blade steak (otherwise known as the "Denver cut"), shoulder steak and shoulder roast, and arm steak and arm roast. The average meat market cuts thick and thin chuck steaks (often sold as chuck steak or chuck steak family pack) from the neck and shoulder, but some markets also cut it from the center of the cross-rib portion. Short ribs are cut from the lip of the roll. Some meat markets will sell cross-rib pot roast under the generic name pot roast. The difference between a pot roast and a cross-rib pot roast is the vertical line of fat separating the two types of chuck meat; the cross-rib pot roast contains the line of fat. This is what creates richness of flavor in the roast.
=== Hybrid === When the parent anticyclone is weaker or not ideally located, the diabatic process must start to contribute in order to develop CAD. In scenarios where there is an equal contribution from dry synoptic forcing and diabatic processes, it is considered a hybrid damming event. The 250-mb jet is weaker and slightly farther south relative to a classical composite 24 hours prior to CAD onset. With the surface parent high farther west, it builds in eastward into the northern Great Plains and western Great Lakes region, located beneath a region of confluent flow from the 250-mb jet.
Normorphine is an opiate analogue, the N-demethylated derivative of morphine, that was first described in the 1950s when a large group of N-substituted morphine analogues were characterized for activity. The compound has relatively little opioid activity in its own right, but is a useful intermediate which can be used to produce both opioid antagonists such as nalorphine, and also potent opioid agonists such as N-phenethylnormorphine. with its formation from morphine catalyzed by the liver enzymes CYP3A4 and CYP2C8. Normorphine is a controlled substance listed under the Single Convention On Narcotic Drugs 1961 and the laws in various states implementing it; for example, in the United States it is a Schedule I Narcotic controlled substance, with an ACSCN of 9313 and an annual aggregate manufacturing quota of 18 grams in 2014, unchanged from the prior year. The salts in use are the free base hexahydrate (free base conversion ratio 0.715), and hydrochloride (0.833).
=== Transitioning to commercial release (2013–2014) === A new version of the Source engine had been introduced by 2013 that, in addition to new engine features, included support for OS X and Linux platforms. However, developers had to pay to gain access to the full feature set of this engine. According to Adam Engels, the project lead at the completion of Black Mesa, Valve approached their team around this time and suggested making Black Mesa a commercial release and, thus, getting a license to the Source engine. The team considered this option, and, since access to the full Source engine would help make Black Mesa the best game they could, opted to go the commercial route to be able to pay for that license, not having originally intended to profit from the game. By November 2013, the team had affirmed that they had gotten Valve's permission to sell the game. Some of the team were later invited to Valve's offices in Bellevue, Washington in 2015. At this point in 2013, the team cautioned that a final version was still some distance away, as they were still dealing with the updated Source engine, and they had not yet done much with Xen. Crowbar Collective continued to offer the free version of Black Mesa, based on the earlier Source engine, on their website. With the new Source engine, the team started to look more closely at how Valve had used Source in Half-Life 2, compared to what they had done in the original Half-Life, and developed changes for Black Mesa that reflected what they believed were Valve's design principles in Half-Life 2.
=== Bone activity === Ribonuclease-enriched lactoferrin has been used to examine how lactoferrin affects bone. Lactoferrin has shown to have positive effects on bone turnover. It has aided in decreasing bone resorption and increasing bone formation. This was indicated by a decrease in the levels of two bone resorption markers (deoxypyridinoline and N-telopeptide) and an increase in the levels two bone formation markers (osteocalcin and alkaline phosphatase). It has reduced osteoclast formation, which signifies a decrease in pro-inflammatory responses and an increase in anti-inflammatory responses which indicates a reduction in bone resorption as well.
Sources: en.wikipedia.org
It is designed as a triple agonist acting on the GLP-1, GIP, and glucagon receptors. This combination is intended to influence appetite, insulin secretion, and energy expenditure. Single-receptor and dual-receptor compounds act on a narrower set of targets.
No. It remains investigational, and phase 3 results have not been fully published or reviewed by regulators. Official approval status should be confirmed through regulatory agencies rather than secondary sources.
The added glucagon receptor activity is the main difference in its mechanism. Whether that addition produces meaningful benefits in clinical outcomes is still being studied. Comparisons between compounds rest largely on indirect rather than head-to-head trial data.
常用质谱测定分子量，再结合肽图或序列分析验证一级结构。单一检测手段一般难以排除结构相近的类似物。多种方法相互印证更为可靠。